BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3493161)

  • 1. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors.
    Braun AR; Chase TN
    Eur J Pharmacol; 1986 Nov; 131(2-3):301-6. PubMed ID: 3493161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Eur J Pharmacol; 1988 Aug; 152(3):289-300. PubMed ID: 2906003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of chronic exposure to selective D-1 and D-2 dopamine receptor agonists.
    Braun AR; Chase TN
    Eur J Pharmacol; 1988 Mar; 147(3):441-51. PubMed ID: 3259931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
    Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1 and D2 dopamine receptor mechanisms in dopaminergic behaviors.
    Koller WC; Herbster G
    Clin Neuropharmacol; 1988 Jun; 11(3):221-31. PubMed ID: 3261198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
    Vasse M; Chagraoui A; Protais P
    Eur J Pharmacol; 1988 Mar; 148(2):221-9. PubMed ID: 2897924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats.
    Dall'Olio R; Gandolfi O; Vaccheri A; Roncada P; Montanaro N
    Psychopharmacology (Berl); 1988; 95(3):381-5. PubMed ID: 2901128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulation.
    Pifl C; Hornykiewicz O
    Eur J Pharmacol; 1988 Jan; 146(1):189-91. PubMed ID: 3258244
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions.
    Barone P; Davis TA; Braun AR; Chase TN
    Eur J Pharmacol; 1986 Apr; 123(1):109-14. PubMed ID: 2872071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses to selective D-1 and D-2 agonists after repeated treatment with selective D-1 and D-2 antagonists.
    Gandolfi O; Dall'olio R; Vaccheri A; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Jun; 30(2):463-9. PubMed ID: 3262877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine antagonism of D-1 and D-2 dopamine receptor-mediated behaviors.
    Criswell HE; Mueller RA; Breese GA
    Eur J Pharmacol; 1989 Jan; 159(2):141-7. PubMed ID: 2495973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213.
    Meller E; Bordi F; Bohmaker K
    Life Sci; 1988; 42(25):2561-7. PubMed ID: 3260320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
    Arnt J; Hyttel J; Perregaard J
    Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups.
    Moody CA; Spear LP
    Psychopharmacology (Berl); 1992; 107(1):39-49. PubMed ID: 1350350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for postsynaptic dopamine agonist effects of B-HT 920 in the presence of the dopamine D-1 agonist SKF 38393.
    Meltzer LT; Wiley JN; Williams AE; Heffner TG
    Psychopharmacology (Berl); 1988; 95(3):329-32. PubMed ID: 2901126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of dopamine D-1 and D-2 receptor agonists on EEG activity and behaviour in the rabbit.
    Ongini E; Caporali MG
    Neuropharmacology; 1987 Apr; 26(4):355-60. PubMed ID: 2953987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors.
    Starr MS; Starr BS
    Pharmacol Biochem Behav; 1989 May; 33(1):41-4. PubMed ID: 2571171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-1/D-2 behavioural interactions in the rat involving striatal dopamine D-1 receptors.
    Starr MS
    Eur J Pharmacol; 1988 Jul; 151(3):479-82. PubMed ID: 3265106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.